{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T22:33:38Z","timestamp":1784154818905,"version":"3.55.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s00210-023-02420-w","type":"journal-article","created":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T16:04:46Z","timestamp":1676477086000},"page":"1535-1545","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Ferulic acid-loaded nanostructure prevents morphine reinstatement: the involvement of dopamine system, NRF2, and \u0394FosB in the striatum brain area of rats"],"prefix":"10.1007","volume":"396","author":[{"given":"Laura Hautrive","family":"Milanesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenika Rubert","family":"Rossato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9ssica Leandra Oliveira","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edvia Ferraz","family":"D\u2019avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin\u00edcia Garzella","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila Reck","family":"Rampelotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane Gon\u00e7alves","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scheila Rezende","family":"Schaffazick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane","family":"de Bona da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilise E.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,15]]},"reference":[{"issue":"3","key":"2420_CR1","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3390\/ijms18030550","volume":"18","author":"T Asano","year":"2017","unstructured":"Asano T, Matsuzaki H, Iwata N, Xuan M, Kamiuchi S, Hibino Y, Sakamoto T, Okazaki M (2017) Protective effects of ferulic acid against chronic cerebral hypoperfusion-induced swallowing dysfunction in rats. Int J Mol Sci 18(3):550. https:\/\/doi.org\/10.3390\/ijms18030550","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2420_CR2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.2174\/1871527317666180816095707","volume":"18","author":"MH Askar","year":"2019","unstructured":"Askar MH et al (2019) Effects of exercise and ferulic acid on alpha synuclein and neuroprotective heat shock protein 70 in an experimental model of parkinsonism disease. CNS Neurol Disord Drug Targets 18(2):156\u2013169","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"2","key":"2420_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10522-008-9160-8","volume":"10","author":"E Barone","year":"2009","unstructured":"Barone E, Calabrese V, Mancuso C (2009) Ferulic acid and its therapeutic potential as a hormetin for age-related diseases. Biogerontology 10(2):97\u2013108","journal-title":"Biogerontology"},{"issue":"21","key":"2420_CR4","doi-asserted-by":"publisher","first-page":"9967","DOI":"10.1021\/acs.jmedchem.6b01178","volume":"59","author":"M Benchekroun","year":"2016","unstructured":"Benchekroun M et al (2016) The antioxidant additive approach for Alzheimer\u2019s disease therapy: new ferulic (lipoic) acid plus melatonin modified tacrines as cholinesterases inhibitors, direct antioxidants, and nuclear factor (erythroid-derived 2)-like 2 activators. J Med Chem 59(21):9967\u20139973","journal-title":"J Med Chem"},{"issue":"9","key":"2420_CR5","doi-asserted-by":"publisher","first-page":"830","DOI":"10.3390\/antiox9090830","volume":"9","author":"P Berr\u00edos-C\u00e1rcamo","year":"2020","unstructured":"Berr\u00edos-C\u00e1rcamo P, Quezada M, Quintanilla ME, Morales P, Ezquer M, Herrera-Marschitz M, Israel Y, Ezquer F (2020) Oxidative stress and neuroinflammation as a pivot in drug abuse. A focus on the therapeutic potential of antioxidant and anti-inflammatory agents and biomolecules. Antioxidants (Basel) 9(9):830. https:\/\/doi.org\/10.3390\/antiox9090830","journal-title":"Antioxidants (Basel)"},{"key":"2420_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2021.111544","volume":"198","author":"EJ Calabrese","year":"2021","unstructured":"Calabrese EJ, Agathokleous E, Calabrese V (2021) Ferulic acid and hormesis: biomedical and environmental implications. Mech Ageing Dev 198:111544","journal-title":"Mech Ageing Dev"},{"issue":"6","key":"2420_CR7","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3109\/10715761003709802","volume":"44","author":"X Chen","year":"2010","unstructured":"Chen X et al (2010) 2\u2032,7\u2032-Dichlorodihydrofluorescein as a fluorescent probe for reactive oxygen species measurement: forty years of application and controversy. Free Radic Res 44(6):587\u2013604","journal-title":"Free Radic Res"},{"key":"2420_CR8","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.brainres.2008.02.090","volume":"1209","author":"CY Cheng","year":"2008","unstructured":"Cheng CY et al (2008) Ferulic acid provides neuroprotection against oxidative stress-related apoptosis after cerebral ischemia\/reperfusion injury by inhibiting ICAM-1 mRNA expression in rats. Brain Res 1209:136\u2013150","journal-title":"Brain Res"},{"key":"2420_CR9","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.biopsych.2008.05.025","volume":"64","author":"H Cohen","year":"2008","unstructured":"Cohen H et al (2008) Early post-stressor intervention with high-dose corticosterone attenuates posttraumatic stress response in an animal model of posttraumatic stress disorder. Biol Psychiatry 64:708\u2013717","journal-title":"Biol Psychiatry"},{"issue":"2","key":"2420_CR10","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1152\/jn.00459.2001","volume":"87","author":"P Congar","year":"2002","unstructured":"Congar P, Bergevin A, Trudeau LE (2002) D2 receptors inhibit the secretory process downstream from calcium influx in dopaminergic neurons: implication of K+ channels. J Neurophysiol 87(2):1046\u20131056","journal-title":"J Neurophysiol"},{"issue":"4","key":"2420_CR11","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1007\/s13311-021-01116-4","volume":"18","author":"M Congiu","year":"2021","unstructured":"Congiu M et al (2021) N-Acylethanolamine acid amidase inhibition potentiates morphine analgesia and delays the development of tolerance. Neurotherapeutics 18(4):2722\u20132736","journal-title":"Neurotherapeutics"},{"issue":"5","key":"2420_CR12","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/bcpt.12821","volume":"121","author":"VT Dias","year":"2017","unstructured":"Dias VT et al (2017) Could modafinil prevent psychostimulant addiction? An experimental study in rats. Basic Clin Pharmacol Toxicol 121(5):400\u2013408","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"2420_CR13","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1111\/ejn.12644","volume":"40","author":"BJ Everitt","year":"2014","unstructured":"Everitt BJ (2014) Neural and psychological mechanisms underlying compulsive drug seeking habits and drug memories\u2014indications for novel treatments of addiction. Eur J Neurosci 40(1):2163\u20132182","journal-title":"Eur J Neurosci"},{"key":"2420_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neuroscience.2014.01.025","volume":"282","author":"CP Ford","year":"2014","unstructured":"Ford CP (2014) The role of D2-autoreceptors in regulating dopamine neuron activity and transmission. Neuroscience 282:13\u201322","journal-title":"Neuroscience"},{"issue":"20","key":"2420_CR15","doi-asserted-by":"publisher","first-page":"6975","DOI":"10.1523\/JNEUROSCI.1020-10.2010","volume":"30","author":"CP Ford","year":"2010","unstructured":"Ford CP et al (2010) Control of extracellular dopamine at dendrite and axon terminals. J Neurosci 30(20):6975\u20136983","journal-title":"J Neurosci"},{"key":"2420_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neubiorev.2018.03.020","volume":"89","author":"E Galaj","year":"2018","unstructured":"Galaj E, Ewing S, Ranaldi R (2018) Dopamine D1 and D3 receptor polypharmacology as a potential treatment approach for substance use disorder. Neurosci Biobehav Rev 89:13\u201328","journal-title":"Neurosci Biobehav Rev"},{"issue":"12","key":"2420_CR17","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1016\/j.euroneuro.2015.09.015","volume":"25","author":"P Georgiou","year":"2015","unstructured":"Georgiou P et al (2015) The oxytocin analogue carbetocin prevents priming-induced reinstatement of morphine-seeking: involvement of dopaminergic, noradrenergic and MOPr systems. Eur Neuropsychopharmacol 25(12):2459\u20132464","journal-title":"Eur Neuropsychopharmacol"},{"key":"2420_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.neuropharm.2014.01.006","volume":"87","author":"J Goncalves","year":"2014","unstructured":"Goncalves J, Baptista S, Silva AP (2014) Psychostimulants and brain dysfunction: a review of the relevant neurotoxic effects. Neuropharmacology 87:135\u2013149","journal-title":"Neuropharmacology"},{"key":"2420_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.lfs.2016.08.011","volume":"179","author":"P Hassanzadeh","year":"2017","unstructured":"Hassanzadeh P et al (2017) Ferulic acid exhibits antiepileptogenic effect and prevents oxidative stress and cognitive impairment in the kindling model of epilepsy. Life Sci 179:9\u201314","journal-title":"Life Sci"},{"key":"2420_CR20","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0014-2999(02)02874-1","volume":"459","author":"A Holems","year":"2003","unstructured":"Holems A, Rodgers RJ (2003) Prior exposure to the elevated plus-maze sensitizes mice to the acute behavioral effects of fluoxetine and phenelzine. Eur J Pharmacol 459:221\u2013230","journal-title":"Eur J Pharmacol"},{"key":"2420_CR21","doi-asserted-by":"publisher","unstructured":"Hu R, Song R, Yang R, Su R, Li J (2013) The dopamine D3 receptor antagonist YQA14 that inhibits the expression and drug-primed reactivation of morphine-induced conditioned place preference in rats. Eur J Pharmacol. S0014\u20132999(13). https:\/\/doi.org\/10.1016\/j.ejphar.2013.10.026","DOI":"10.1016\/j.ejphar.2013.10.026"},{"key":"2420_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bbr.2015.04.018","volume":"290","author":"S Ikemoto","year":"2015","unstructured":"Ikemoto S, Yang C, Tan A (2015) Basal ganglia circuit loops, dopamine and motivation: a review and enquiry. Behav Brain Res 290:17\u201331","journal-title":"Behav Brain Res"},{"issue":"435","key":"2420_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2022.114076","volume":"28","author":"CHA Jesus","year":"2022","unstructured":"Jesus CHA et al (2022) Cannabidiol enhances the antinociceptive effects of morphine and attenuates opioid-induced tolerance in the chronic constriction injury model. Behav Brain Res 28(435):114076","journal-title":"Behav Brain Res"},{"issue":"8","key":"2420_CR24","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1176\/appi.ajp.162.8.1403","volume":"162","author":"PW Kalivas","year":"2005","unstructured":"Kalivas PW, Volkow ND (2005) The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 162(8):1403\u20131413","journal-title":"Am J Psychiatry"},{"key":"2420_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.redox.2012.10.001","volume":"1","author":"E Kansanen","year":"2013","unstructured":"Kansanen E et al (2013) The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer. Redox Biol 1:45\u201349","journal-title":"Redox Biol"},{"issue":"5","key":"2420_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0955-2863(01)00215-7","volume":"13","author":"J Kanski","year":"2002","unstructured":"Kanski J et al (2002) Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: structure-activity studies. J Nutr Biochem 13(5):273\u2013281","journal-title":"J Nutr Biochem"},{"key":"2420_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev.pharmtox.46.120604.141046","volume":"47","author":"TW Kensler","year":"2007","unstructured":"Kensler TW, Wakabayashi N, Biswal S (2007) Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 47:89\u2013116","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"2","key":"2420_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0893-133X(00)00195-0","volume":"24","author":"GF Koob","year":"2001","unstructured":"Koob GF, Le Moal M (2001) Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24(2):97\u2013129","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"2420_CR29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/npp.2009.110","volume":"35","author":"GF Koob","year":"2010","unstructured":"Koob GF, Volkow ND (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35(1):217\u2013238","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"2420_CR30","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","volume":"3","author":"GF Koob","year":"2016","unstructured":"Koob GF, Volkow ND (2016) Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry 3(8):760\u2013773","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"2420_CR31","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s11011-015-9725-6","volume":"30","author":"J Lenzi","year":"2015","unstructured":"Lenzi J et al (2015) Ferulic acid chronic treatment exerts antidepressant-like effect: role of antioxidant defense system. Metab Brain Dis 30(6):1453\u20131463","journal-title":"Metab Brain Dis"},{"key":"2420_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.fct.2013.12.024","volume":"65","author":"C Mancuso","year":"2014","unstructured":"Mancuso C, Santangelo R (2014) Ferulic acid: pharmacological and toxicological aspects. Food Chem Toxicol 65:185\u2013195","journal-title":"Food Chem Toxicol"},{"key":"2420_CR33","doi-asserted-by":"crossref","unstructured":"Marcellino D, et al (2008) Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum. J Biol Chem, 283(38): p. 26016\u201325","DOI":"10.1074\/jbc.M710349200"},{"issue":"7","key":"2420_CR34","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1021\/acschemneuro.1c00691","volume":"13","author":"CC Martins","year":"2022","unstructured":"Martins CC et al (2022) Contribution of opioid and nitrergic systems to m-trifluoromethyl diphenyl diselenide attenuates morphine-induced tolerance in mice. ACS Chem Neurosci 13(7):910\u2013919","journal-title":"ACS Chem Neurosci"},{"key":"2420_CR35","doi-asserted-by":"crossref","unstructured":"Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2004;(3):CD002207. https:\/\/doi.org\/10.1002\/14651858.CD002207.pub2","DOI":"10.1002\/14651858.CD002207.pub2"},{"key":"2420_CR36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.fct.2017.09.048","volume":"110","author":"LH Milanesi","year":"2017","unstructured":"Milanesi LH et al (2017) Toxicological aspects of the interesterified-fat from processed foods: influences on opioid system and its reward effects in rats. Food Chem Toxicol 110:25\u201332","journal-title":"Food Chem Toxicol"},{"key":"2420_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.toxlet.2019.03.009","volume":"308","author":"LH Milanesi","year":"2019","unstructured":"Milanesi LH et al (2019) Mediterranean X Western based diets: opposite influences on opioid reinstatement. Toxicol Lett 308:7\u201316","journal-title":"Toxicol Lett"},{"key":"2420_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2021.105157","volume":"150","author":"LH Milanesi","year":"2021","unstructured":"Milanesi LH et al (2021) Topiramate-chitosan nanoparticles prevent morphine reinstatement with no memory impairment: dopaminergic and glutamatergic molecular aspects in rats. Neurochem Int 150:105157","journal-title":"Neurochem Int"},{"key":"2420_CR39","first-page":"254","volume":"48","author":"K Montgomery","year":"1955","unstructured":"Montgomery K (1955) The relation between fear induced by novel stimulation and exploratory behavior. J Comp Physiol 48:254\u2013260","journal-title":"J Comp Physiol"},{"issue":"1","key":"2420_CR40","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1124\/jpet.105.083410","volume":"314","author":"DL Muller","year":"2005","unstructured":"Muller DL, Unterwald EM (2005) D1 dopamine receptors modulate deltaFosB induction in rat striatum after intermittent morphine administration. J Pharmacol Exp Ther 314(1):148\u2013154","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"2420_CR41","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.biopsych.2011.08.011","volume":"71","author":"JW Muschamp","year":"2012","unstructured":"Muschamp JW et al (2012) DeltaFosB enhances the rewarding effects of cocaine while reducing the pro-depressive effects of the kappa-opioid receptor agonist U50488. Biol Psychiatry 71(1):44\u201350","journal-title":"Biol Psychiatry"},{"issue":"2&3","key":"2420_CR42","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/FBP.0000000000000546","volume":"31","author":"F Nazari-Serenjeh","year":"2020","unstructured":"Nazari-Serenjeh F et al (2020) D1- but not D2-like dopamine receptor antagonist in the CA1 region of the hippocampus reduced stress-induced reinstatement in extinguished morphine-conditioning place preference in the food-deprived rats. Behav Pharmacol 31(2&3):196\u2013206","journal-title":"Behav Pharmacol"},{"key":"2420_CR43","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ejphar.2014.10.034","volume":"753","author":"EJ Nestler","year":"2015","unstructured":"Nestler EJ (2015) FosB: a transcriptional regulator of stress and antidepressant responses. Eur J Pharmacol 753:66\u201372","journal-title":"Eur J Pharmacol"},{"issue":"20","key":"2420_CR44","doi-asserted-by":"publisher","first-page":"11042","DOI":"10.1073\/pnas.191352698","volume":"98","author":"EJ Nestler","year":"2001","unstructured":"Nestler EJ, Barrot M, Self DW (2001) DeltaFosB: a sustained molecular switch for addiction. Proc Natl Acad Sci U S A 98(20):11042\u201311046","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2420_CR45","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95(2):351\u2013358","journal-title":"Anal Biochem"},{"issue":"7","key":"2420_CR46","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.neuropharm.2011.03.010","volume":"61","author":"CM Olsen","year":"2011","unstructured":"Olsen CM (2011) Natural rewards, neuroplasticity, and non-drug addictions. Neuropharmacology 61(7):1109\u20131122","journal-title":"Neuropharmacology"},{"key":"2420_CR47","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.2147\/IJN.S38378","volume":"9","author":"S Onoue","year":"2014","unstructured":"Onoue S, Yamada S, Chan HK (2014) Nanodrugs: pharmacokinetics and safety. Int J Nanomedicine 9:1025\u20131037","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"2420_CR48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","volume":"16","author":"JK Patra","year":"2018","unstructured":"Patra JK et al (2018) Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology 16(1):71","journal-title":"J Nanobiotechnology"},{"key":"2420_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2021.105259","volume":"78","author":"CR Rampelotto","year":"2022","unstructured":"Rampelotto CR et al (2022) Ferulic acid-loaded nanocapsules: evaluation of mucosal interaction, safety and antioxidant activity in human mononucleated cells. Toxicol in Vitro 78:105259","journal-title":"Toxicol in Vitro"},{"issue":"5","key":"2420_CR50","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1046\/j.1460-9568.1998.00173.x","volume":"10","author":"S Ridray","year":"1998","unstructured":"Ridray S et al (1998) Coexpression of dopamine D1 and D3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions. Eur J Neurosci 10(5):1676\u20131686","journal-title":"Eur J Neurosci"},{"issue":"2","key":"2420_CR51","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s12035-009-8053-4","volume":"39","author":"SD Robertson","year":"2009","unstructured":"Robertson SD, Matthies HJ, Galli A (2009) A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters. Mol Neurobiol 39(2):73\u201380","journal-title":"Mol Neurobiol"},{"key":"2420_CR52","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ejphar.2016.06.031","volume":"788","author":"K Roversi","year":"2016","unstructured":"Roversi K et al (2016) Trans fat intake across gestation and lactation increases morphine preference in females but not in male rats: behavioral and biochemical parameters. Eur J Pharmacol 788:210\u2013217","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"2420_CR53","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1046\/j.1471-4159.2003.02050.x","volume":"87","author":"Y Schmitz","year":"2003","unstructured":"Schmitz Y et al (2003) Presynaptic regulation of dopaminergic neurotransmission. J Neurochem 87(2):273\u2013289","journal-title":"J Neurochem"},{"key":"2420_CR54","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.bbr.2014.01.005","volume":"262","author":"HJ Segat","year":"2014","unstructured":"Segat HJ et al (2014) Exercise modifies amphetamine relapse: behavioral and oxidative markers in rats. Behav Brain Res 262:94\u2013100","journal-title":"Behav Brain Res"},{"key":"2420_CR55","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.brainresbull.2017.09.013","volume":"135","author":"HJ Segat","year":"2017","unstructured":"Segat HJ et al (2017) Influence of physical activity on addiction parameters of rats exposed to amphetamine which were previously supplemented with hydrogenated vegetable fat. Brain Res Bull 135:69\u201376","journal-title":"Brain Res Bull"},{"key":"2420_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2018.11.017","volume":"21","author":"F Sivandzade","year":"2019","unstructured":"Sivandzade F et al (2019) NRF2 and NF-B interplay in cerebrovascular and neurodegenerative disorders: molecular mechanisms and possible therapeutic approaches. Redox Biol 21:101059","journal-title":"Redox Biol"},{"issue":"2","key":"2420_CR57","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3164\/jcbn.40.92","volume":"40","author":"M Srinivasan","year":"2007","unstructured":"Srinivasan M, Sudheer AR, Menon VP (2007) Ferulic acid: therapeutic potential through its antioxidant property. J Clin Biochem Nutr 40(2):92\u2013100","journal-title":"J Clin Biochem Nutr"},{"key":"2420_CR58","doi-asserted-by":"crossref","unstructured":"Surmeier DJ, et al Are neostriatal dopamine receptors co-localized? Trends Neurosci. 16: p. 299\u2013305","DOI":"10.1016\/0166-2236(93)90103-S"},{"issue":"2","key":"2420_CR59","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.pbb.2008.11.015","volume":"92","author":"AM Teixeira","year":"2009","unstructured":"Teixeira AM et al (2009) Intense exercise potentiates oxidative stress in striatum of reserpine-treated animals. Pharmacol Biochem Behav 92(2):231\u2013235","journal-title":"Pharmacol Biochem Behav"},{"issue":"6","key":"2420_CR60","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1177\/0269881109102613","volume":"24","author":"PK Thanos","year":"2010","unstructured":"Thanos PK et al (2010) Conditioned place preference and locomotor activity in response to methylphenidate, amphetamine and cocaine in mice lacking dopamine D4 receptors. J Psychopharmacol 24(6):897\u2013904","journal-title":"J Psychopharmacol"},{"key":"2420_CR61","unstructured":"The diagnostic and statistical manual of mental disorders (5th ed.; DSM\u20135; American Psychiatric Association, 2013)"},{"issue":"6","key":"2420_CR62","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1111\/ejn.12112","volume":"37","author":"S Tobin","year":"2013","unstructured":"Tobin S et al (2013) Antagonism of the dopamine D1-like receptor in mesocorticolimbic nuclei attenuates acute food deprivation-induced reinstatement of heroin seeking in rats. Eur J Neurosci 37(6):972\u2013981","journal-title":"Eur J Neurosci"},{"key":"2420_CR63","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.pbb.2013.07.015","volume":"119","author":"M Tops","year":"2014","unstructured":"Tops M et al (2014) Why social attachment and oxytocin protect against addiction and stress: insights from the dynamics between ventral and dorsal corticostriatal systems. Pharmacol Biochem Behav 119:39\u201348","journal-title":"Pharmacol Biochem Behav"},{"key":"2420_CR64","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.colsurfb.2013.04.005","volume":"109","author":"S Trombino","year":"2013","unstructured":"Trombino S et al (2013) Trans-ferulic acid-based solid lipid nanoparticles and their antioxidant effect in rat brain microsomes. Colloids Surf B Biointerfaces 109:273\u2013279","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2420_CR65","unstructured":"World Drug Report (2020)\u00a0Cross Cutting Issues \u2013 Opioid Crisis (United Nations publication, Sales No. E.20. XI.6 (Booklet 4))"},{"issue":"2","key":"2420_CR66","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1742-7843.2006.pto_461.x","volume":"99","author":"B Xu","year":"2006","unstructured":"Xu B et al (2006) Heroin-administered mice involved in oxidative stress and exogenous antioxidant-alleviated withdrawal syndrome. Basic Clin Pharmacol Toxicol 99(2):153\u2013161","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"4","key":"2420_CR67","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s11011-013-9404-4","volume":"28","author":"Y Xu","year":"2013","unstructured":"Xu Y et al (2013) Ferulic acid increases pain threshold and ameliorates depression-like behaviors in reserpine-treated mice: behavioral and neurobiological analyses. Metab Brain Dis 28(4):571\u2013583","journal-title":"Metab Brain Dis"},{"issue":"8","key":"2420_CR68","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41386-018-0284-5","volume":"44","author":"ZB You","year":"2019","unstructured":"You ZB et al (2019) Dopamine D3R antagonist VK4-116 attenuates oxycodone self-administration and reinstatement without compromising its antinociceptive effects. Neuropsychopharmacology 44(8):1415\u20131424","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"2420_CR69","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1159\/000491755","volume":"31","author":"K Zdunska","year":"2018","unstructured":"Zdunska K et al (2018) Antioxidant properties of ferulic acid and its possible application. Skin Pharmacol Physiol 31(6):332\u2013336","journal-title":"Skin Pharmacol Physiol"},{"issue":"3","key":"2420_CR70","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.biopsych.2007.06.008","volume":"63","author":"W Zhou","year":"2008","unstructured":"Zhou W, Kalivas PW (2008) N-Acetylcysteine reduces extinction responding and induces enduring reductions in cue- and heroin-induced drug-seeking. Biol Psychiatry 63(3):338\u2013340","journal-title":"Biol Psychiatry"},{"issue":"7589","key":"2420_CR71","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nature16954","volume":"530","author":"Y Zhu","year":"2016","unstructured":"Zhu Y et al (2016) A thalamic input to the nucleus accumbens mediates opiate dependence. Nature 530(7589):219\u2013222","journal-title":"Nature"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02420-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-023-02420-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02420-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T23:09:05Z","timestamp":1686092945000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-023-02420-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,15]]},"references-count":71,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["2420"],"URL":"https:\/\/doi.org\/10.1007\/s00210-023-02420-w","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,15]]},"assertion":[{"value":"1 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare that the animal experiment was approved by the Animal Ethical Committee (Universidade Federal de Santa Maria\u2014UFSM), which is affiliated to the Council for Control of Animal Experiments (CONCEA), following international norms of care and animal maintenance.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}